JÖRG SCHLÖSSER
GENERAL MANAGER, DRG INSTRUMENTS GmbH
Jörg Schlösser is the General Manager for DRG Instruments GmbH, a wholly owned subsidiary of BioCheck, Inc. Founded in 1973 as a subsidiary of DRG International, Inc., and located in Marburg, Germany, DRG Instruments GmbH specializes in the development and production of innovative ELISAs and Chemiluminescent assays, both for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function and many more.
Jörg joined DRG Instruments GmbH as General Manager in April 2022. He brings more than 25 years of extensive experience in general management, sales, market development and operations in the field of medical devices across Europe, Russia and EMEA regions. Prior to joining BioCheck/DRG, he served initially as the Sales and Marketing Director at RADIM Diagnostics, and was then appointed as the General Manager/Managing Director for the business for the past four years.
Jörg received his master’s degree in Electro Engineering and Biomedical Engineering, and is also certified in Six Sigma Green Belt. Jörg and his wife Stefanie have two daughters. In his spare time, he enjoys downhill skiing in the wintertime and bike riding in the summer.
News and Updates
BioCheck Inc Acquires DRG International Inc
Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.
Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL
Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level
Cortisol & Adrenal Androgens as Independent Predictors
Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...